Patrick M. Forde, Arlene A. Forastiere, Julia D. Ransohoff receive ECOG-ACRIN 2023 scientific leadership and mentorship awards

Temozolomide + radiation treatment improves OS for grade 2 gliomas

Both radiation and temozolomide, a generic chemotherapy treatment in pill form, have meaningful single-modality anti-tumor activity against slow-growing, low-grade gliomas.

December 06, 2024

Vol.50 No.45

In Brief

ECOG-ACRIN, Caris collaborate on interrogating TAILORx breast cancer trial

ECOG-ACRIN Cancer Research Group and Caris Life Sciences announced a multi-year research collaboration wherein Caris is pairing its genomic, transcriptomic, and proteomic profiling, advanced artificial intelligence and machine learning algorithms with ECOG-ACRIN’s research capabilities.

October 25, 2024

Vol.50 No.40

Clinical

Randomized trial failed to accrue, but data point to preoperative chemo as viable option in sinonasal cancer

If clinical research were anything like fly fishing, the scientific question that EA3163 trial attempted to answer might be considered “the one that got away”.

Group chairs propose funding strategy to jump-start correlative studies

The National Academy of Medicine recognized the value of correlative science in publicly funded clinical trials in 2010, recommending “the incorporation of innovative science into cancer clinical trials through the support and use of biorepositories.”

Deming, Wakelee, Mouhieddine receive ECOG-ACRIN 2024 scientific leadership, mentorship awards

Dustin A. Deming, Heather A. Wakelee, and Tarek H. Mouhieddine were named recipients of the ECOG-ACRIN Cancer Research Group annual scientific awards, which are funded by the ECOG Research & Education Foundation.

May 17, 2024

Vol.50 No.20

Health Equity

ECOG-ACRIN renames health equity scholarships in honor of Edith Mitchell

The ECOG-ACRIN Cancer Research Group has renamed its Group Meeting Attendance Awards for Minority Trainees to the Edith Peterson Mitchell, MD Health Equity Travel Scholarships.

November 03, 2023

Vol.49 No.41

By Matthew Bin Han Ong

Patrick M. Forde, Arlene A. Forastiere, Julia D. Ransohoff receive ECOG-ACRIN 2023 scientific leadership and mentorship awards

YOU MAY BE INTERESTED IN

Temozolomide + radiation treatment improves OS for grade 2 gliomas

ECOG-ACRIN, Caris collaborate on interrogating TAILORx breast cancer trial

Randomized trial failed to accrue, but data point to preoperative chemo as viable option in sinonasal cancer

Group chairs propose funding strategy to jump-start correlative studies

Deming, Wakelee, Mouhieddine receive ECOG-ACRIN 2024 scientific leadership, mentorship awards

ECOG-ACRIN renames health equity scholarships in honor of Edith Mitchell

Renew today!

Subscriber content

Never miss an issue!

Login